| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 9308480 | Kidney International | 2005 | 9 Pages |
Abstract
Higher CRP and sTNFrii are independently associated with faster rates of kidney function loss in chronic kidney disease. Pravastatin appears to prevent loss of kidney function to a greater extent in individuals with greater evidence of inflammation, although this was of borderline significance. These data suggest that inflammation may mediate the loss of kidney function among subjects with chronic kidney disease and concomitant coronary disease.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Marcello Tonelli, Frank Sacks, Marc Pfeffer, Gian S. Jhangri, Gary Curhan,